Technical Analysis for TARO - Taro Pharmaceutical Industries

Grade Last Price % Change Price Change
D 41.94 -0.47% -0.20
TARO closed down 0.47 percent on Monday, March 18, 2024, on 1.32 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Flat Flat

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
20 DMA Support Bullish -0.47%
Crossed Above 50 DMA Bullish -0.47%
MACD Bullish Signal Line Cross Bullish -0.47%
Bollinger Band Squeeze Range Contraction -0.47%
Three Weeks Tight Range Contraction -0.47%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 15 hours ago
1.5x Volume Pace about 15 hours ago
Outside Day about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
Fell Below 20 DMA about 15 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Taro Pharmaceutical Industries Description

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, together with its subsidiaries, engages in the research, development, production, and marketing of pharmaceutical products primarily in the United States, Canada, and Israel. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas comprising topical creams and ointments, liquids, capsules, and tablets principally in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company also develops and manufactures active pharmaceutical ingredients for use in its finished dosage form products. Taro Pharmaceutical Industries Ltd. sells and distributes its products to drug wholesalers and store chains, generic drug distributors, mass merchandisers, food and retail chains, and managed care organizations. The company was founded in 1959 and is based in Haifa Bay, Israel.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Sciences Medication Pharmaceutical Products Pharmacology Retail Chain Store Chains Pharmaceutical Industries Pharmaceutical Sciences Active Pharmaceutical Ingredients Managed Care Ointments Topical Medication Drug Wholesalers Generic Drug Counter Pharmaceutical Products Patheon Perrigo Science And Technology In Israel Science Based Pharmaceutical

Is TARO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 45.76
52 Week Low 22.89
Average Volume 58,568
200-Day Moving Average 38.73
50-Day Moving Average 42.14
20-Day Moving Average 42.02
10-Day Moving Average 41.94
Average True Range 0.36
RSI (14) 47.92
ADX 26.4
+DI 18.40
-DI 26.70
Chandelier Exit (Long, 3 ATRs) 41.32
Chandelier Exit (Short, 3 ATRs) 41.53
Upper Bollinger Bands 42.52
Lower Bollinger Band 41.52
Percent B (%b) 0.42
BandWidth 2.37
MACD Line -0.02
MACD Signal Line -0.02
MACD Histogram 0.0002
Fundamentals Value
Market Cap 1.58 Billion
Num Shares 37.6 Million
EPS 1.22
Price-to-Earnings (P/E) Ratio 34.38
Price-to-Sales 2.62
Price-to-Book 0.89
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.24
Resistance 3 (R3) 42.27 42.19 42.19
Resistance 2 (R2) 42.19 42.12 42.18 42.17
Resistance 1 (R1) 42.07 42.07 42.03 42.04 42.16
Pivot Point 41.99 41.99 41.98 41.98 41.99
Support 1 (S1) 41.87 41.92 41.83 41.84 41.72
Support 2 (S2) 41.79 41.87 41.78 41.71
Support 3 (S3) 41.67 41.79 41.69
Support 4 (S4) 41.64